Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Haplotype Labs
AddedMar 17, 2024
UpdatedJul 2, 2026
Haplotype Labs

Haplotype Labs

Seed

Empowering personalized prevention through genetic risk models on HaploHub SaaS platform.

Founded
2024
Accelerator
Y Combinator logoY CombinatorW24
Overview
Compare
Fundraising
Employees
Website

Haplotype Labs, founded with a mission to empower personalized prevention through genetics and AI, offers the HaploHub SaaS platform. This platform is designed for genetic testing labs, concierge medical practices, and payer/providers to predict disease risk using proprietary or publicly available genetic models. HaploHub enables secure hosting, management, and interrogation of genetic data, and allows users to generate reports and run common inference algorithms without needing to write code.

Notable figures affiliated with Haplotype Labs include experts in genetics and AI, though specific names are not provided. The company has achieved significant milestones by integrating advanced genetic risk models into a user-friendly SaaS platform, enhancing the ability of healthcare providers to offer personalized preventive care. Its impact lies in revolutionizing how genetic data is utilized for disease prediction and management, contributing to more proactive and personalized healthcare solutions.

Haplotype Labs - Similar Companies

Probably Genetic logo

Probably Genetic

Nest Genomics logo

Nest Genomics

nestgenomics.com

Genomelink logo

Genomelink

genomelink.io

Nucleus logo

Nucleus

Allelica logo

Allelica

allelica.com

FamGenix logo

FamGenix

famgenix.com

WhiteLab Genomics logo

WhiteLab Genomics

whitelabgx.com

ThinkGenetic logo

ThinkGenetic

thinkgenetic.com

Basepair logo

Basepair

basepairtech.com

Generation Lab logo

Generation Lab

generationlab.co

Geno.Me logo

Geno.Me

yourgeno.me

My Gene Counsel logo

My Gene Counsel

mygenecounsel.com

Invitae logo

Invitae

invitae.com

Emedgene logo

Emedgene

emedgene.com

Genetica logo

Genetica

genetica.asia

Haplotype Labs - Quick Facts

Who are Haplotype Labs' competitors?

Companies similar to Haplotype Labs include Probably Genetic, Nest Genomics, Genomelink and Nucleus.

When was Haplotype Labs founded?

Haplotype Labs was founded in 2024.

When was Haplotype Labs' last funding round?

Haplotype Labs' most recent funding round was for $500k (USD) in January 2024.

How much has Haplotype Labs raised to-date?

As of Jan 1, 2024, Haplotype Labs has raised a total of $500k (USD).

How many employees does Haplotype Labs have?

Haplotype Labs has 1 employee as of Apr 28, 2024.

Haplotype Labs - Classification

Ownership
  • Venture Capital
Technology
  • AI
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Genetic Testing
Tags
  • SaaS